Description
Adjuvant endocrine therapy in pre- and perimenopausal women with breast cancer: practice guidelines
- You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart
Article: Adjuvant endocrine therapy in pre- and perimenopausal women with breast cancer: practice guidelines
€2.42
